WeedMD Inc. (TSXV:WMD) and Phivida Holdings Inc (CSE:VIDA) were recently featured in an article by the St. Thomas Times-Journal, which discusses the companies recent partnership to create a new liquid product that will be for sale across Canada.

As quoted in the article,


If all goes well the product will be manufactured at WeedMD’s new facility in Strathroy.

“I think it’s important to be in the beverage space,” said Keith Merker, chief financial officer for WeedMD. “As human being we’re used to consuming our intoxicants; we drink wine, we drink beer, we drink spirits. And we like to do it in a social setting.”

Cannabis is still a contentious issue. Studies suggest as many as 68 per cent of Canadians believe it should be legalized, which still leaves 32 per cent of the population at odds with current federal legislature to legalize it later this year.

Many of those same people have no problem with alcohol, Merker said.

“If we can create a product that has similar effects to alcohol . . . but has much less in the way of toxicity, then I think we have a winner,” Merker said.

Click here to read the full article

Click here to connect with WeedMD Inc. (TSXV:WMD) for an Investor Presentation.

Click here to connect with Phivida Holdings Inc (CSE:VIDA) for an Investor Presentation.

Source: www.stthomastimesjournal.com

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less